These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5883214)

  • 21. Levels of dihydrofolate reductase and thymidylate synthetase in strains of Streptococcus faecium resistant to substituted pyrimidines, triazines and MTX.
    Smith CC; Freisheim JH
    Ann N Y Acad Sci; 1971 Nov; 186():182-4. PubMed ID: 5002296
    [No Abstract]   [Full Text] [Related]  

  • 22. Structure-activity analysis of tetrahydrofolate analogs using sutstituent constants and regression analysis.
    Miller E; Hansch C
    J Pharm Sci; 1967 Jan; 56(1):92-7. PubMed ID: 6030502
    [No Abstract]   [Full Text] [Related]  

  • 23. Irreversible enzyme inhibitors. CLIX. Effect of substitution on transport and isozyme specificity of p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)-o-chlorophenoxyacetamido-benzenesulfonyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase.
    Baker BR; Ashton WT
    J Med Chem; 1969 Sep; 12(5):894-7. PubMed ID: 5812207
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tetrahydrofolic-dependent enzymes and dihydrofolic reductase in normal and psoriasic human epidermis and in cutaneous epithelial neoplasms].
    Finzi AF; Martelli M; Tonato M; Colonna A; Grignani F
    Minerva Dermatol; 1965 Dec; 40(12):449-56. PubMed ID: 5218347
    [No Abstract]   [Full Text] [Related]  

  • 25. ANALOGS OF TETRAHYDROFOLIC ACID. 18. ON THE MODE OF BINDING OF SOME 6-ARYL- AND 6-ARALKYLPYRIMIDINES TO FOLIC REDUCTASE.
    BAKER BR; SHAPIRO HS; WERKHEISER WC
    J Med Chem; 1965 May; 8():283-7. PubMed ID: 14323133
    [No Abstract]   [Full Text] [Related]  

  • 26. Irreversible enzyme inhibitors. 173. Cure of Walker 256 ascites by reversible and irreversible inhibitors of dihydrofolic reductase derived from 1-(substituted-phenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
    Baker BR; Vermeulen NM; Ashton WT; Ryan AJ
    J Med Chem; 1970 Nov; 13(6):1130-40. PubMed ID: 5479852
    [No Abstract]   [Full Text] [Related]  

  • 27. Irreversible enzyme inhibitors. 108. p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. IV. Effects of substitution on the propionamide bridge on isozyme specificity.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jul; 11(4):672-7. PubMed ID: 5244345
    [No Abstract]   [Full Text] [Related]  

  • 28. Irreversible enzyme inhibitors. CXXVII. p-(2,6-diamino-1,2-dihydro--2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. 3. Effects of modification of the propionamide bridge on isozyme specificity.
    Baker BR; Luorens GJ
    J Med Chem; 1968 Jul; 11(4):666-72. PubMed ID: 5244344
    [No Abstract]   [Full Text] [Related]  

  • 29. ANALOGS OF TETRAHYDROFOLIC ACID. XIV. FACILE SYNTHETIC ROUTE TO THE 2-AMINO-5-(3-ANILINOPROPYL)-6-METHYL-4-PYRIMIDINOL TYPE OF FOLIC REDUCTASE AND THYMIDYLATE SYNTHETASE INHIBITOR.
    BAKER BR; SANTI DV; SHAPIRO HS
    J Pharm Sci; 1964 Nov; 53():1317-25. PubMed ID: 14253585
    [No Abstract]   [Full Text] [Related]  

  • 30. Irreversible enzyme inhibitors. CXXIX. p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. V. Effects of substitution on the benzenesulfonyl fluoride moiety on isozyme specificity.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jul; 11(4):677-82. PubMed ID: 5244346
    [No Abstract]   [Full Text] [Related]  

  • 31. Irreversible enzyme inhibitors. LXXXIV. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. IX. Derivatives of 2,4-diaminopyrimidine. 3.
    Baker BR; Meyer RB
    J Pharm Sci; 1967 May; 56(5):570-6. PubMed ID: 6032766
    [No Abstract]   [Full Text] [Related]  

  • 32. Irreversible enzyme inhibitors. LXXXII. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. VII. Derivatives of 2,4-diaminopyrimidine. I.
    Baker BR; Jackson GD; Meyer RB
    J Pharm Sci; 1967 May; 56(5):566-70. PubMed ID: 6040577
    [No Abstract]   [Full Text] [Related]  

  • 33. ANALOGS OF TETRAHYDROFOLIC ACID. XV. MODE OF BINDING OF 2,4-DIAMINOPYRIMIDINES TO FOLIC REDUCTASE AND THYMIDYLATE SYNTHETASE.
    BAKER BR; HO BT
    J Pharm Sci; 1964 Dec; 53():1457-66. PubMed ID: 14255122
    [No Abstract]   [Full Text] [Related]  

  • 34. Irreversible enzyme inhibitors. CXLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[p-(p-fluorosulfonylphenylureidomethyl)phenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
    Baker BR; Lourens GJ
    J Med Chem; 1969 Jan; 12(1):101-4. PubMed ID: 5763002
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
    Gangjee A; Lin X; Kisliuk RL; McGuire JJ
    J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triazines and related products. Part XV. 2,4-Diaminopyrimidines and 2-aminopyrimidin-4(3H)-ones bearing 1,2,3-benzotriazinyl groups as potential dihydrofolic reductase inhibitors.
    Brown TB; Stevens MF
    J Chem Soc Perkin 1; 1975; (11):1023-8. PubMed ID: 1170192
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibitors of dihydrofolic acid reductase in the therapy of infectious diseases.
    Hitchings GH
    Bibl Nutr Dieta; 1966; 8():226-37. PubMed ID: 5331137
    [No Abstract]   [Full Text] [Related]  

  • 38. Irreversible enzyme inhibitors. CV. Differential irreversible inhibition of vertebrate dihydrofolic reductases by derivatives of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazines substituted with a terminal sulfonyl fluoride.
    Baker BR; Lourens GJ
    J Med Chem; 1967 Nov; 10(6):1113-22. PubMed ID: 6056040
    [No Abstract]   [Full Text] [Related]  

  • 39. 2,4-Diamino-6,7-dihydro-5H-cyclopenta[d]pyrimidine analogues of trimethoprim as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase.
    Rosowsky A; Papoulis AT; Queener SF
    J Med Chem; 1998 Mar; 41(6):913-8. PubMed ID: 9526565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DIFFERENTIAL INHIBITION OF DIHYDROFOLIC REDUCTASE FROM DIFFERENT SPECIES.
    BAKER BR; BENG-THONG HO
    J Pharm Sci; 1964 Sep; 53():1137-8. PubMed ID: 14234921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.